BUY Lupin Limited — Rajesh Bhosale, Angel One
byRajesh Bhosale, Angel OneHorizon: 1 year26 Aug 2026via NDTV Profit
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Lupin receives US FDA approval for Modafinil 100 mg, 200 mg tablets
NewsCnbc-Tv18·4 Sept · 2d ago
Lupin Ltd has received approval from the U.S. FDA for its Modafinil Tablets, USP.
BSE · Company Update·4 Sept · 2d ago
1 advisor has an active short-term BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·28 Aug · 1w ago
Lupin wins ruling on Vertex patents for cystic fibrosis drug
NewsCnbc-Tv18·26 Aug · 2w ago
8 other SEBI-registered advisors have active long-term BUY calls on this stock, with 2 issued in the last 14 days
Advisor consensus · same horizon·27 Aug · 2w ago
1 other SEBI-registered advisor has an active long-term SELL call on this stock, issued in the last 14 days
Advisor consensus · same horizon·27 Aug · 1w ago
Lupin share falls 2%; Citi downgrades to Sell, cuts target price to Rs 2,050
NewsEt-Markets·27 Aug · 2w ago
Lupin share price: Citi downgrades, cuts target; Bernstein sees Kalydeco ruling as key positive
NewsCnbc-Tv18·27 Aug · 2w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Lupin
- BUY — Aditya Agarwal, Coheron Brokers22 Oct 2026 · ~2 weeks · target ₹2,100 · Active
- BUY — Rajesh Satpute16 Oct 2026 · Same day · target ₹2,035 · Expired
- BUY — Sumeet Bagadia, Choice Broking29 Sept 2026 · ~2 weeks · target ₹2,150 · Expired
- BUY — Jigar S Patel, Anand Rathi28 Sept 2026 · ~3 months · target ₹2,300 · SL hit
- BUY — Siddharth Rai Mangala22 Sept 2026 · Same day · target ₹2,160 · Expired
More from Rajesh Bhosale, Angel One
- BUY The Indian Hotels Company6 Oct 2026 · ~2 weeks · target ₹755 · SL hit
- BUY Bharat Heavy Electricals6 Oct 2026 · ~2 weeks · target ₹475 · SL hit
- SELL Avenue Supermarts5 Oct 2026 · ~2 weeks · target ₹3,500 · Target hit
- BUY Aurobindo Pharma29 Sept 2026 · ~2 weeks · target ₹1,760 · SL hit
- BUY The Indian Hotels Company29 Sept 2026 · ~2 weeks · target ₹760 · Expired

